ArticleCureus2026
Management of Chronic Seromas and the Role of Bleomycin Sclerotherapy: A Two-Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Seroma is a common postoperative complication after several plastic surgery operations. They mostly resolve on their own, but from time to time, they can persist and become chronic. This article reports two cases of persistent seromas, a post-abdominoplasty seroma and a Morel-Lavallée lesion, successfully treated with intralesional bleomycin and reviews their etiology, prevention, and treatment with a focus on sclerotherapy. The different choices of sclerosants are discussed with their mechanism of action, focusing on bleomycin, which was used in two different cases of persistent seromas successfully without complication. To our knowledge, this article is the first to report the clinical use of bleomycin as a sclerosant for the treatment of seroma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.